151 related articles for article (PubMed ID: 23274377)
21. Recognition and management of macrophage activation syndrome in juvenile arthritis.
Kelly A; Ramanan AV
Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
[TBL] [Abstract][Full Text] [Related]
22. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
[TBL] [Abstract][Full Text] [Related]
23. Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome.
Strippoli R; Caiello I; De Benedetti F
J Rheumatol; 2013 Jun; 40(6):761-7. PubMed ID: 23588947
[TBL] [Abstract][Full Text] [Related]
24. Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2.
Tasaki Y; Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Wada T; Yachie A
Cytokine; 2016 Apr; 80():1-6. PubMed ID: 26908294
[TBL] [Abstract][Full Text] [Related]
25. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
26. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Rosenblum ND; Feldman BM; Laxer RM; Schneider R
J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377
[TBL] [Abstract][Full Text] [Related]
27. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.
Grom AA; Villanueva J; Lee S; Goldmuntz EA; Passo MH; Filipovich A
J Pediatr; 2003 Mar; 142(3):292-6. PubMed ID: 12640378
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
[TBL] [Abstract][Full Text] [Related]
31. [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
Li CF; He XH; Kuang WY; Han TX; Zhou YF
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):806-11. PubMed ID: 17274865
[TBL] [Abstract][Full Text] [Related]
32. Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis.
An Q; Jin MW; An XJ; Xu SM; Wang L
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4322-4326. PubMed ID: 29077164
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
34. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Behrens EM; Beukelman T; Paessler M; Cron RQ
J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
[TBL] [Abstract][Full Text] [Related]
35. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
Zeng P; Li F; Zeng H
Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Ko G; Saikawa Y; Kubota T; Yamasaki Y; Takei S; Yachie A
Clin Immunol; 2015 Oct; 160(2):277-81. PubMed ID: 26101092
[TBL] [Abstract][Full Text] [Related]
37. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Ravelli A; Magni-Manzoni S; Pistorio A; Besana C; Foti T; Ruperto N; Viola S; Martini A
J Pediatr; 2005 May; 146(5):598-604. PubMed ID: 15870661
[TBL] [Abstract][Full Text] [Related]
38. The genetics of macrophage activation syndrome.
Schulert GS; Cron RQ
Genes Immun; 2020 May; 21(3):169-181. PubMed ID: 32291394
[TBL] [Abstract][Full Text] [Related]
39. Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
Schulert GS; Zhang M; Husami A; Fall N; Brunner H; Zhang K; Cron RQ; Grom AA
Arthritis Rheumatol; 2018 Jun; 70(6):963-970. PubMed ID: 29409136
[TBL] [Abstract][Full Text] [Related]
40. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
